Aharon Gal
Chief Strategy & Growth OfficerNovartis
PharmaceuticalsView Profile →Executive Vice President, Head of Research & Development · Sanofi
Paulo Fontoura is Sanofi’s executive vice president and head of Research & Development, following clinical-development leadership at Roche and service as founding chief medical officer of Xaira Therapeutics.
Last reviewed: Nov 15, 2026
Paulo Fontoura is Sanofi’s executive vice president and head of Research & Development, following clinical-development leadership at Roche and service as founding chief medical officer of Xaira Therapeutics.
Fontoura earned his MD and PhD at the New University of Lisbon and completed postdoctoral research at Stanford University School of Medicine. His professional background combines academic neurology, translational science and the development of medicines.
He spent more than 15 years at Roche, progressing through senior positions to become senior vice president and global head of clinical development for neuroscience, immunology, ophthalmology, infectious and rare diseases. He led an international organization of physicians and clinical scientists managing late-stage development across those therapeutic areas.
Fontoura subsequently became the founding chief medical officer of Xaira Therapeutics, a biotechnology company applying artificial intelligence to drug discovery and development. Sanofi appointed him executive vice president and global head of R&D effective September 1, 2026.
His Sanofi remit spans research, translational medicine, clinical development, medical and regulatory affairs. Alongside industry work, he teaches at the New University of Lisbon Medical School and the European Center of Pharmaceutical Medicine in Basel. He is a Fellow of the American Academy of Neurology and has authored more than 85 research publications.
Fontoura earned his MD and PhD at the New University of Lisbon and undertook postdoctoral research at Stanford University School of Medicine.